Keyphrases
Anti-EGFR Antibody
20%
Cancer Xenograft Model
20%
Cell Proliferation
20%
Cetuximab
100%
Colorectal Cancer Patients
20%
EGF Receptor
100%
EGFR Extracellular Domain
20%
Extracellular Domain
20%
Intracellular Domain
20%
Methylation
100%
Methylation Status
20%
Model Expression
20%
Orthotopic Colorectal Cancer
20%
Overall Survival
20%
Post-translational Modification
20%
PRMT1
100%
Receptor Dimerization
20%
Receptor Signaling
20%
Recurrence Rate
20%
Signaling Activation
40%
Sustained Signaling
20%
Tumor Growth
20%
Biochemistry, Genetics and Molecular Biology
Arginine
100%
Cell Proliferation
10%
Cetuximab
100%
Dimerization
10%
Epidermal Growth Factor Receptor
100%
Methylation
100%
Methyltransferase
100%
Monoclonal Antibody
10%
Overall Survival
10%
Posttranslational Modification
10%
Tumor Progression
10%
Pharmacology, Toxicology and Pharmaceutical Science
Cetuximab
100%
Colorectal Carcinoma
20%
Epidermal Growth Factor Receptor
100%
Monoclonal Antibody
10%
Overall Survival
10%
Protein Arginine Methyltransferase
100%
Receptor
10%
Recurrence Risk
10%
Tumor Growth
10%